Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Topiramate in schizophrenia: a review of effects on psychopathology and metabolic parameters.

Hahn MK, Cohn T, Teo C, Remington G.

Clin Schizophr Relat Psychoses. 2013 Jan;6(4):186-96. doi: 10.3371/CSRP.HACO.01062013. Review.

PMID:
23302448
2.

Efficacy of metformin and topiramate in prevention and treatment of second-generation antipsychotic-induced weight gain.

Ellinger LK, Ipema HJ, Stachnik JM.

Ann Pharmacother. 2010 Apr;44(4):668-79. doi: 10.1345/aph.1M550. Epub 2010 Mar 16. Review.

PMID:
20233913
3.

Clozapine augmented with glutamate modulators in refractory schizophrenia: a review and metaanalysis.

Veerman SR, Schulte PF, Begemann MJ, Engelsbel F, de Haan L.

Pharmacopsychiatry. 2014 Sep;47(6):185-94. doi: 10.1055/s-0034-1383656. Epub 2014 Jul 7. Review.

PMID:
25002291
4.

Augmentation strategies in partial responder and/or treatment-resistant schizophrenia patients treated with clozapine.

Muscatello MR, Bruno A, De Fazio P, Segura-Garcia C, Pandolfo G, Zoccali R.

Expert Opin Pharmacother. 2014 Nov;15(16):2329-45. doi: 10.1517/14656566.2014.956082. Epub 2014 Oct 5. Review.

PMID:
25284216
5.

Augmentation strategies in clozapine-resistant schizophrenia.

Remington G, Saha A, Chong SA, Shammi C.

CNS Drugs. 2005;19(10):843-72. Review.

PMID:
16185094
6.
7.

Clozapine augmentation: safety and efficacy.

Chong SA, Remington G.

Schizophr Bull. 2000;26(2):421-40. Review.

PMID:
10885641
8.

Metabolic side effects of antipsychotic medication.

Tschoner A, Engl J, Laimer M, Kaser S, Rettenbacher M, Fleischhacker WW, Patsch JR, Ebenbichler CF.

Int J Clin Pract. 2007 Aug;61(8):1356-70. Review.

PMID:
17627711
9.

Does the addition of a second antipsychotic drug improve clozapine treatment?

Barbui C, Signoretti A, Mulè S, Boso M, Cipriani A.

Schizophr Bull. 2009 Mar;35(2):458-68. doi: 10.1093/schbul/sbn030. Epub 2008 Apr 23. Review.

10.
11.

[Leponex, 10 years after -- a clinical review].

Llorca PM, Pere JJ.

Encephale. 2004 Sep-Oct;30(5):474-91. Review. French.

PMID:
15627052
12.

Obesity and related metabolic abnormalities during antipsychotic drug administration: mechanisms, management and research perspectives.

Baptista T, Kin NM, Beaulieu S, de Baptista EA.

Pharmacopsychiatry. 2002 Nov;35(6):205-19. Review.

PMID:
12518268
13.

Practical issues with amisulpride in the management of patients with schizophrenia.

Pani L, Villagrán JM, Kontaxakis VP, Alptekin K.

Clin Drug Investig. 2008;28(8):465-77. Review.

PMID:
18598092
14.

Clozapine: key discussion points for prescribers.

Hill M, Freudenreich O.

Clin Schizophr Relat Psychoses. 2013 Jan;6(4):177-85. doi: 10.3371/CSRP.HIFR.01062013. Review.

PMID:
23302447
15.

Augmentation with sulpiride for a schizophrenic patient partially responsive to clozapine.

Stubbs JH, Haw CM, Staley CJ, Mountjoy CQ.

Acta Psychiatr Scand. 2000 Nov;102(5):390-3; discussion 393-4. Review.

PMID:
11098812
16.

Augmentation strategies of clozapine with antipsychotics in the treatment of ultraresistant schizophrenia.

Mouaffak F, Tranulis C, Gourevitch R, Poirier MF, Douki S, Olié JP, Lôo H, Gourion D.

Clin Neuropharmacol. 2006 Jan-Feb;29(1):28-33. Review.

PMID:
16518132
17.

Could maternal perinatal atypical antipsychotic treatments program later metabolic diseases in the offspring?

Guillemot J, Laborie C, Dutriez-Casteloot I, Maron M, Deloof S, Lesage J, Breton C, Vieau D.

Eur J Pharmacol. 2011 Sep 30;667(1-3):13-6. doi: 10.1016/j.ejphar.2011.05.076. Epub 2011 Jun 12. Review.

PMID:
21664905
18.

Review: Combination therapy with non-clozapine atypical antipsychotic medication: a review of current evidence.

Chan J, Sweeting M.

J Psychopharmacol. 2007 Aug;21(6):657-64. Epub 2006 Nov 8. Review.

PMID:
17092976
19.

[The place of SSRIs in the treatment of schizophrenia].

Zullino D, Delacrausaz P, Baumann P.

Encephale. 2002 Sep-Oct;28(5 Pt 1):433-8. Review. French.

PMID:
12386545
20.

When symptoms persist: clozapine augmentation strategies.

Buckley P, Miller A, Olsen J, Garver D, Miller DD, Csernansky J.

Schizophr Bull. 2001;27(4):615-28. Review.

PMID:
11824488

Supplemental Content

Support Center